Racial Differences in Antipsychotic Medication Dosage
Author Information
Author(s): Bakare Muideen O
Primary Institution: Federal Neuro-Psychiatric Hospital, New Haven, Enugu, Nigeria
Hypothesis
Is there a racial difference in the effective therapeutic dosage of antipsychotic medications in patients with psychotic symptoms?
Conclusion
There may be actual racial influences on the response to antipsychotic medications, suggesting the need for new treatment guidelines.
Supporting Evidence
- Studies show higher dosages of antipsychotic medications prescribed for African-American patients compared to Caucasians.
- Empirical observations indicate that antipsychotic prescription patterns in Sub-Saharan Africa deviate from Western guidelines.
- Research suggests that genetic differences may influence how different races respond to antipsychotic medications.
Takeaway
Different races might need different amounts of medicine to feel better when they have psychotic symptoms.
Potential Biases
Potential biases in prescribing practices and clinician attitudes may affect the findings.
Limitations
The study relies on empirical observations and lacks controlled studies to confirm the hypothesis.
Participant Demographics
Focus on African-American and Caucasian patients, with implications for Sub-Saharan African populations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website